Pfizer Pharmaceuticals Korea Launches Pneumococcal and Influenza Vaccination Campaign to Combat Rising Flu Cases
Pfizer Pharmaceuticals Korea Raises Awareness for Pneumococcal and Influenza Vaccination Campaign Entered on October 27, 2023, at 14:55. Viewed 7 times. Pfizer Pharmaceuticals Korea has announced its initiative to launch a comprehensive campaign promoting the significance of pneumococcal and influenza vaccinations for the public. To commemorate the flu season, the campaign will feature renowned actress […]
Winners of the 21st Pfizer Medical Awards in Korea Announced
Winners of the 21st Pfizer Medical Awards announced The winners of the 21st Pfizer Medical Awards, sponsored by Pfizer Pharmaceutical Korea and hosted by the Korean Academy of Medical Sciences, were announced on the 26th. The awards recognize excellence in the fields of basic medicine, clinical medicine, and translational medicine. Basic Medicine Award Winner: Professor […]
Winners of the 21st Pfizer Medical Prize Announced, Recognizing Outstanding Contributions in Medicine
Winners Announced for the 21st Pfizer Medical Prize Professor Ji Heon-young, Park Deok-woo, and Kim Nam-guk have been selected as winners of the 21st Pfizer Medical Prize, hosted by the Korean Academy of Medical Sciences and sponsored by Pfizer Pharmaceuticals Korea. Winners in Each Category Basic Medicine Award: Professor Ji Heon-young (Department of Pharmacology, Yonsei […]
Maharat Nakhon Ratchasima Hospital Offers Walk-In Flu Vaccination and Free COVID Booster Without Registration
Maharat Nakhon Ratchasima Hospital Extends Invitation for Free Flu and COVID Vaccinations Maharat Nakhon Ratchasima Hospital cordially invites individuals interested in receiving injection services for both the COVID-19 vaccine and the flu vaccine. This exclusive offer provides an opportunity for 1,000 people to receive their vaccinations without any prior registration. The hospital’s dedicated medical team […]
Exploring the Final Frontier: Pharmaceutical Companies Sending Drugs into Space for Testing
Advancements in Space Exploration Enable Drug Testing in Orbit Global warming has led to an increase in disease outbreaks, prompting countries to urgently develop drugs to combat pathogens. As the world grapples with an aging population, medicine has become indispensable in alleviating and treating various diseases. The National Academies of Sciences, Engineering, and Medicine highlight […]
New Study Reveals Insights into Hormone Resistance in HR+/HER2- Breast Cancer and Potential Solutions
Researchers Identify Biomarkers for Hormone-Resistant Breast Cancer Hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer prognosis is generally favorable, especially with hormone suppression treatment. However, hormone resistance poses a challenge in cases of recurrent and aggressive metastatic breast cancer. Recently, a research team may have found a breakthrough in addressing […]
Samsung Biologics Signs Record-Breaking $1.2 Trillion Consignment Manufacturing Agreement with Pfizer
Samsung Biologics Signs Record-Breaking 1.2 Trillion Won Consignment Manufacturing Agreement In a groundbreaking development for the pharmaceutical industry, Samsung Biologics has recently secured a consignment manufacturing agreement (CMO) worth a staggering 1.2 trillion won. This landmark deal has surpassed the value of last year’s annual contract held by the Chief Medical Officer, cementing Samsung Biologics’ […]
Samsung BioLogics Signs $1.2 Trillion Contract Manufacturing Organization (CMO) Deal with Pfizer
Samsung BioLogics Signs a $897 Million CMO Contract with Pfizer, The Largest Deal in Company History Panoramic view of Samsung Biologics 3rd Plant / Photo = Samsung Bilogics Samsung BioLogics, a leading biopharmaceutical contract development and manufacturing company (CMDO), has captured the attention of the industry with a contract manufacturing organization (CMO) deal worth 1.2 […]
Cibinco Tab. receives approval as an oral JAK inhibitor for chronic severe atopic dermatitis
Pfizer Korea Pharmaceutical has announced the approval of Cibinco, an oral JAK inhibitor, for the treatment of chronic severe atopic dermatitis in adults and adolescents aged 12 years and older. The medication has been added to health insurance benefits, allowing for greater accessibility for patients. Atopic dermatitis is a chronic inflammatory skin disease that affects […]
Cibinco: A New Oral JAK Inhibitor Approved for Chronic Severe Atopic Dermatitis
Pfizer Korea Pharmaceutical has recently received approval for its oral JAK inhibitor, Cibinco, as a treatment for adults and adolescents with chronic severe atopic dermatitis. This innovative product is now covered by health insurance benefits, providing hope for patients suffering from this debilitating condition. Chronic severe atopic dermatitis is a condition that affects approximately 10% […]
